| LP286585-7 | Mycoplasma hyopneumoniae Ab sample/Positive control | COMPONENT | 1 |
| LP286587-3 | Myeloblasts/100 leukocytes | COMPONENT | 1 |
| LP286593-1 | Myelocytes/100 leukocytes | COMPONENT | 1 |
| LP286594-9 | Myelocytes/leukocytes | COMPONENT | 9 |
| LP286596-4 | Myocardial mass.end diastole/Body surface area | COMPONENT | 4 |
| LP286597-2 | Myocardial mass.end diastole/Height exp 2.7 | COMPONENT | 4 |
| LP286598-0 | Myocardial mass/Body surface area | COMPONENT | 5 |
| LP286599-8 | Myocardial mass/Height exp 2.7 | COMPONENT | 4 |
| LP286600-4 | Myoglobin/Creatinine | COMPONENT | 1 |
| LP286601-2 | Myristate/Creatinine | COMPONENT | 1 |
| LP286602-0 | Myristoleate/Creatinine | COMPONENT | 1 |
| LP286603-8 | Mytilus edulis Ab.IgE/IgE.total | COMPONENT | 1 |
| LP286604-6 | N,N'-dimethylarginine/Creatinine | COMPONENT | 1 |
| LP286605-3 | N,N-dimethylarginine/Creatinine | COMPONENT | 1 |
| LP286606-1 | N6-Acetyl-L-lysine/Creatinine | COMPONENT | 1 |
| LP286607-9 | N-acetylaspartate/Creatinine | COMPONENT | 2 |
| LP286608-7 | N-acetyl-beta-glucosaminidase/Creatinine | COMPONENT | 1 |
| LP286609-5 | N-acetyl-L-aspartate/Creatinine | COMPONENT | 2 |
| LP286610-3 | N-acetyltyrosine/Creatinine | COMPONENT | 2 |
| LP286611-1 | NADH cytochrome C reductase/Citrate synthase | COMPONENT | 1 |
| LP286612-9 | N-alpha acetyllysine/Creatinine | COMPONENT | 1 |
| LP286613-7 | Naltrexone/Creatinine | COMPONENT | 1 |
| LP286614-5 | Naproxen/Creatinine | COMPONENT | 1 |
| LP286615-2 | Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286616-0 | Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286617-8 | Natural killer cell cytotoxicity.100:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286618-6 | Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286619-4 | Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP28662-2 | Diameter | COMPONENT | 79 |
| LP286620-2 | Natural killer cell cytotoxicity.25:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286621-0 | Natural killer cell cytotoxicity.3.13:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286622-8 | Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286623-6 | Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286624-4 | Natural killer cell cytotoxicity.50:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286625-1 | Natural killer cell cytotoxicity.6.25:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286626-9 | Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286627-7 | Natural killer cell cytotoxicity.IL-2 stimulated 0.9:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286628-5 | Natural killer cell cytotoxicity.IL-2 stimulated 1.88:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286629-3 | Natural killer cell cytotoxicity.IL-2 stimulated 15:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286630-1 | Natural killer cell cytotoxicity.IL-2 stimulated 3.75:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286631-9 | Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286632-7 | Natural killer cell cytotoxicity.IL-2 stimulated 7.5:1 effector to target cell ratio/Positive control | COMPONENT | 1 |
| LP286633-5 | N-carbamoyl beta alanine/Creatinine | COMPONENT | 1 |
| LP286634-3 | N-desalkylflurazepam/Creatinine | COMPONENT | 1 |
| LP286635-0 | Neisseria meningitdis B Ag | COMPONENT | 1 |
| LP286638-4 | Neisseria meningitidis serogroups A+B+C+w135+Y Ag | COMPONENT | 1 |
| LP286640-0 | Neopterin/Creatinine | COMPONENT | 2 |
| LP286641-8 | Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total | COMPONENT | 2 |
| LP286642-6 | Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total | COMPONENT | 2 |
| LP286645-9 | Neutrophils.band form/leukocytes | COMPONENT | 16 |